Operating Segments (Details) - Schedule of operating segments - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020	Jun. 30, 2019	Dec. 31, 2019
Revenues
Revenues	$ 505,288	$ 1,544,964	$ 1,429,842	$ 2,689,752
Income/(Loss) from Operations
Loss from Operations	(2,813,872)	(2,164,891)	(11,287,661)	(4,464,954)
Amortization and Depreciation Expense
Amortization and Depreciation Expense	17,802	12,932	35,448	22,992
Other Income, Net
Other Income, Net	37,109	41,370	92,671	91,130
Share-Based Compensation
Share-Based Compensation	81,003	72,892	144,694	152,465
Identifiable Assets
Identifiable Assets	12,260,674		12,260,674		$ 7,775,360
Public Health Solutions [Member]
Revenues
Revenues	468,009	1,095,865	1,376,818	1,776,218
Income/(Loss) from Operations
Loss from Operations	(50,737)	204,121	(209,239)	195,110
Amortization and Depreciation Expense
Amortization and Depreciation Expense	7,318	4,316	14,621	8,718
Share-Based Compensation
Share-Based Compensation	8,377	8,072	17,842	13,268
Identifiable Assets
Identifiable Assets	273,943		273,943		1,018,673
Specialized BioTherapeutics [Member]
Revenues
Revenues	37,279	449,099	53,024	913,534
Income/(Loss) from Operations
Loss from Operations	(1,808,652)	(1,462,334)	(9,166,503)	(2,798,891)
Amortization and Depreciation Expense
Amortization and Depreciation Expense	3,167	4,168	6,237	8,845
Other Income, Net
Other Income, Net	35,091	(2,339)	68,706	2,670
Share-Based Compensation
Share-Based Compensation	18,962	19,094	44,251	40,002
Identifiable Assets
Identifiable Assets	86,639		86,639		41,705
Corporate [Member]
Income/(Loss) from Operations
Loss from Operations	(954,483)	(905,678)	(1,911,919)	(1,861,173)
Amortization and Depreciation Expense
Amortization and Depreciation Expense	7,317	4,448	14,590	5,429
Other Income, Net
Other Income, Net	2,018	43,709	23,965	88,460
Share-Based Compensation
Share-Based Compensation	53,664	$ 45,726	82,601	$ 99,195
Identifiable Assets
Identifiable Assets	$ 11,900,092		$ 11,900,092		$ 6,714,982